Friday, November 22

Tag: Dr Lal PathLabs

Just Dial, UTI MF, IRCTC in Fortune India Next 500 List
News

Just Dial, UTI MF, IRCTC in Fortune India Next 500 List

Just Dial, UTI Asset Management Company and IRCTC are among the firms that have made it to the Fortune Next 500 list of Indian companies, which has been topped by Dynamatic Technologies. Companies featuring in the Next 500 list are mostly mid-sized and termed as the small wonders by the magazine. Dynamatic Technologies tops the list with an annual revenue of over Rs 1,693 crore followed by Nectar Lifescience (Rs 1,692 crore), Oswal Wollen Mills (Rs 1,689 crore), VRL Logistics (Rs 1,682.5 crore) and Hitachi Home & Life Solutions (Rs 1,682.18 crore). Nectar Lifescience is a new entry in the list, while other four companies have shown improvements in their respective rankings from last year. According to the magazine, together Next 500 companies have generated a revenue of Rs 5,...
Dr Lal PathLabs sees blockbuster listing on BSE; stock up 31%
News

Dr Lal PathLabs sees blockbuster listing on BSE; stock up 31%

Shares of India's biggest diagnostic chain Dr Lal PathLabs listed with a strong premium of almost 31% over the issue price of Rs 550 on Tuesday. On BSE, Dr Lal's stock opened at Rs 717, up 30.36% as against the issue price. Within minutes of trade, it touched a high of Rs 747 and a low of Rs 715.50. The stock listed at Rs 720, a steep gain of 30.9% on NSE. The company commands a market valuation of Rs 6,142.16 crore. Dr Lal's IPO was a big success with 33.41 times over-subscription. In the IPO, the qualified institutional buyers (QIBs) part was subscribed 63.56 times and non-institutional investors saw 61.28 times subscription. The retail investors category was subscribed 4.24 times. Prior to Dr Lal's IPO, Alkem, S H Kelkar, VRL Logistics, Power Mech Projects and Syngene Intern...